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(57) ABSTRACT 
A compact heat exchanger for vena-venous perfusion-in-
duced hyperthermia includes an integral pneumatic pump 
and a hollow tubule heat exchange array. A vena-venous 
perfusion-induced hyperthermia system incorporating the 
compact heat exchanger is described. The heat exchanger 
provides a compact, efficient design allowing a lesser heat 
exchanging surface area and lesser required pumping power 
compared to conventional systems. In turn, the system 
provides a shorter blood circuit compared to conventional 
systems, allowing maintaining a lower blood temperature 
than such conventional systems while supplying sufficiently 
heated blood to patient visceral organs to provide a thera-
peutic effect, such as in supplementing chemotherapy drugs. 
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COMPACT HEAT EXCHANGER FOR 
VENO-VENOUS PERFUSION-INDUCED 
SYSTEMIC HYPERTHERMIA SYSTEMS 
This application claims the benefit of priority in U.S. 
Provisional Patent Application Ser. Nos. 61/522,411 filed on 
Aug. 11, 2011 and 61/651,164 filed on May 24, 2012, the 
entirety of the disclosures of each of which are incorporated 
herein by reference. 
2 
TECHNICAL FIELD 
includes, a compact heat exchanger including an integral 
pneumatic pump and blood flow redirector structures. The 
device of the present disclosure provides an even blood flow 
pattern, preventing or reducing incidence of thrombosis. In 
turn, the presently disclosed design simplifies the blood 
circuit and also provides a pulsatile blood flow pattern, 
promoting active blood mixing and thereby improving gas 
exchange within the pump. The present device finds use at 
least as a supplemental therapy for conventional chemo-
10 therapy regimens. 
The present invention relates generally to the field of 
medical devices. In particular, the invention relates to a 
compact heat exchanger for use in vena-venous perfusion 15 
induced systemic hyperthermia (vv-PISH) systems. 
BACKGROUND OF THE INVENTION 
In 2007 lung cancer was responsible for 31% of all 20 
cancer-related deaths. Advanced stage NSCLC present in 
7 5% of all new lung cancer cases provides a median survival 
rate of only 9-12 months despite maximal combination 
chemotherapy. Despite improvements in cancer therapies, 
the long-term prognosis for patients with metastatic lung 25 
cancer remains dismal, and indeed chemotherapy provides 
only a modest improvement in survival over supportive care 
alone. 
It has been shown that regional and local hyperthermia 
exhibits synergism with various conventional chemotherapy 30 
agents. Hyperthermia selectively kills cancer cells and 
enhances cytotoxicity of certain chemotherapy drugs, 
increases tumor blood flow and permeability of tumor blood 
vessels, and thereby increases drug delivery into a tumor. 
For example, hyperthermia enhances platinum uptake and 35 
inhibits platinum-induce DNA adduct repair, an effect that 
may be important in reversing cisplatin resistance. Thus, 
concurrent combined hyperthermia and chemotherapy has 
great potential in advanced NCSCLC therapy. 
Because advanced stage NSCLC patients often have 40 
metastasis to remote sites, it is contemplated that systemic 
hyperthermia would provide advantages over local hyper-
thermia. Systemic hyperthermia causes marked physiologi-
cal changes, but damage to normal tissue occurs when 
temperatures exceed 44 C. Heat has a selective killing effect 45 
on malignant phenotypes (lung, colon, and pancreatic can-
cers, for example) at temperatures between those exhibited 
during normal fevers and temperatures that induce tissue 
destruction (41-45 C). This suggests that a hyperthermia 
therapeutic window may exist for cancer therapy. However, 50 
conventional heat delivery such as radiant heat disadvanta-
geously redistributes blood flow away from visceral organs 
to skin, and peripheral tissue, resulting in heterogenous heat 
distribution. This leads to insufficient heat delivery to pro-
vide a therapeutic benefit, compromising treatment effi- 55 
ciency, and also induces pain and peripheral nerve damage. 
In turn, conventional vena-venous perfusion-induced hyper-
thermia systems, because of their relatively long tubing 
lengths and requiring multiple cannulations (increased cir-
cuit lengths), must heat blood to unacceptable temperatures 60 
( 46 C and above) to provide the desired hyperthermic effect, 
risking damage to blood cells and pain to the patient. 
To solve this and other problems, the present disclosure 
provides a vena-venous perfusion-induced hyperthermia 
system (vv-PISH) which delivers more heat to visceral 65 
organs for metastatic cancer treatment while eliminating 
complications and disadvantages of radiant heat. The system 
SUMMARY OF THE INVENTION 
The present disclosure provides a blood heat exchanger 
for use as a supplement or replacement therapeutic treatment 
to conventional chemotherapy. The heat exchanger includes 
an integral pneumatic pump enclosed substantially within a 
housing thereof, providing a compact and efficient design. 
Inlet blood redirectors and outlet blood collectors are pro-
vided, which in combination with the integral pneumatic 
pump promote an even perfusion and mixing of blood, 
eliminating areas of stagnation and improving heat 
exchange. 
In an embodiment, an atrium is provided at an inlet of the 
blood heat exchanger. The atrium is defined by one or more 
additional pneumatic pumps for promoting blood flow from 
a patient body into the heat exchanger. By cyclically main-
taining an internal pressure of the atrium pneumatic pump(s) 
at zero or less, a constant, even supply of blood from the 
patient is provided at the blood heat exchanger inlet, thereby 
eliminating the pulsatile inlet blood flow patterns provided 
by conventional pumping systems. 
In turn, a vena-venous perfusion-induced systemic hyper-
thermia system (vv-PISH) incorporating the heat exchanger 
of the present disclosure is described, for removing cooler 
blood from a patient body and returning heated blood to 
same. 
These and other embodiments, aspects, advantages, and 
features of the present invention will be set forth in the 
description which follows, and in part will become apparent 
to those of ordinary skill in the art by reference to the 
following description of the invention and referenced draw-
ings or by practice of the invention. The aspects, advantages, 
and features of the invention are realized and attained by 
means of the instrumentalities, procedures, and combina-
tions particularly pointed out in the appended claims. Unless 
otherwise indicated, any references discussed herein are 
specifically incorporated by reference in their entirety into 
the present disclosure. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying drawings incorporated in and forming 
a part of the specification, illustrate several aspects of the 
present invention, and together with the description serve to 
explain the principles of the invention. In the drawings: 
FIG. 1 shows a housing for the heat exchanger of the 
present disclosure; 
FIG. 2 shows a cross-sectional side view of the heat 
exchanger 
FIG. 3 shows an inlet blood flow redirector for the heat 
exchanger; 
FIG. 4 shows a top view of the heat exchanger of the 
disclosure: 
FIG. 5 shows a cross-sectional side view of the heat 
exchanger, including an integrated pneumatic pump, 
US 9,468,557 B2 
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FIGS. 6a and 6b show the heat exchanger including an 
atrium, in diastolic phase (FIG. 6a) and in systolic phase 
(FIGS. 6b); and 
FIG. 7 graphically depicts relative internal pressures of 
the atrium and heat exchanger in systolic and diastolic 5 
phases. 
DETAILED DESCRIPTION OF THE 
ILLUSTRATED EMBODIMENTS 
4 
10 towards the blood outlet 16 (see arrows), eliminating 
stagnant blood flow in the heat exchanger 10. In turn, a 
blood collection channel 32 is provided at a top of the heat 
exchanger 10, whereby blood exiting the heat exchanging 
tubule array 22 is collected and redirected to the blood outlet 
16 (see FIGS. 2 and 4). A substantially crescent-shaped 
blood collection channel 32 is shown, although the skilled 
artisan will appreciate that other cross-sectional shapes are 
possible and contemplated, such as segmental, triangular, 
In the following detailed description of the illustrated 
embodiments, reference is made to the accompanying draw-
ings that form a part hereof, and in which is shown by way 
of illustration, specific embodiments in which the invention 
may be practiced. These embodiments are described in 
sufficient detail to enable those skilled in the art to practice 
the invention. Also, it is to be understood that other embodi-
ments may be utilized and that process, reagent, software, 
and/or other changes may be made without departing from 
the scope of the present invention. 
10 etc. The blood collection channel 32 regulates blood flow 
evenly at the outlet end of the heat exchanger 10, and further 
guides blood to the blood outlet 16. That is, blood enters via 
the blood inlet 14 and is evenly redirected by the inlet blood 
flow redirector 28 as summarized above to pass over the heat 
15 exchanging tubule array 22. On exiting the heat exchanging 
tubule array 22, blood passes into the blood collection 
channel32 and therefrom exits the heat exchanger 10 via the 
blood outlet 16. In that manner, areas of stagnant blood flow 
at or near the blood outlet 16 are reduced or eliminated. 
20 In turn, a blood collection channel 32 is provided at a top 
of the heat exchanger 10, whereby blood exiting the heat 
exchanging tubule array 22 is collected and redirected to the 
blood outlet 16 (see FIGS. 2 and 4). A substantially crescent-
shaped blood collection channel 32 is shown, although the 
In one aspect, the present disclosure provides a compact 
heat exchanger 10 (see FIG. 1) including a housing 12, at 
least one blood inlet 14, and at least one blood outlet 16. At 
least one heated fluid inlet 18 and at least one heated fluid 
outlet 20 are provided for supplying a heated fluid to and 
removing same from the heat exchanger 10, typically with 
the heated fluid being passed through a hollow heat 
exchanging tubule array 22 of the heat exchanger 10 in a 
counter-current direction compared to that of the blood flow. 
The heat exchanging tubule array 22 may be fabricated of 
any suitable heat exchanging metal. In an embodiment, the 
tubules of the heat exchanging tubule array 22 are fabricated 
25 skilled artisan will appreciate that other cross-sectional 
shapes are possible and contemplated, such as segmental, 
triangular, ect. The blood collection channel 32 regulates 
blood flow evenly at the outlet end of the heat exchanger 10, 
and further guides blood to the blood outlet 16. That is, 
of 0.2 mm thick stainless steel tubing and provide approxi-
mately 0.095-0.113 m2 of total heat exchanging surface. 
30 blood enters via the blood inlet 14 and is evenly redirected 
by the inlet blood flow redirector 28 as summarized above 
to pass over the heat exchanging tubule array 22. On exiting 
the heat exchanging tubule array 22, blood passes into the 
blood collection channel 32 and therefrom exits the heat 
35 exchanger 10 via the blood outlet 16. In manner, areas of 
stagnant blood flow at or near the blood outlet 16 are 
reduced or eliminated. 
As shown in FIG. 2, arrays 22 of heat exchanging tubules 
may be provided arranged substantially parallel to a longi-
tudinal axis of the heat exchanger 10 housing 12, or alter-
natively diagonal spirally wound heat exchanging tubule 
arrays 22 (not shown) may be provided. Inlet potting 24 and 
outlet potting 26, known in the art, is provided and disposed 40 
to prevent entry of blood into the lumens of the hollow heat 
exchanging tubules of the heat exchanging tubule array 22 
and direct mixing with the heated fluid contained therein. 
The inlet potting 24 may define an inverted dome shape, 
further assisting in promoting even redistribution of blood 45 
passing through the heat exchanger 10. The inlet potting 24 
may define an inverted dome shape, further assisting in 
promoting even redistribution of blood passing through the 
heat exchanger 10. 
The system 10 of the invention further includes blood 50 
flow redirector structures, providing an even blood flow 
pattern as blood passes through the heat exchanger 10. An 
inlet blood flow redirector 28 is provided at an end of the 
heat exchanger 10 distal from the blood inlet 14 for evenly 
redirecting blood flow passing through the blood inlet 14. In 55 
an embodiment, a frusta-conical inlet blood flow redirector 
28 is provided at a distal end of the blood inlet 14 (see FIG. 
3), secured to or molded with the distal end of the blood inlet 
14 by one or more columns 30. At least a portion of the 
conical inlet blood flow redirector 28 is disposed in an 60 
interior of the blood inlet 14 distal end. Like structures are 
described in U.S. Pat. No. 8,906,300, filed concurrently 
herewith and incorporated herein in its entirety by reference. 
As shown in FIG. 2, the inlet blood flow redirector 28 
promotes even radial perfusion across a surface of the inlet 65 
potting 24 at a bottom of the heat exchanger and also even 
axial blood flow as blood travels through the heat exchanger 
Rather than utilizing an external pump as is common with 
conventional heat exchangers, the heat exchanger 10 of the 
present disclosure includes an integral pneumatic pump to 
provide pumping action for passing blood from the blood 
inlet 14, over the heat exchanging tubule array 22, and to the 
blood outlet 16. As such, a compact, economical and effi-
cient combination of pump and heat exchanger is provided. 
Providing further advantages, the integral pneumatic pump 
provides a pulsatile blood flow pattern, promoting active 
blood mixing as the blood passes through the heat exchanger 
10, for improved heat exchange performance and an 
improved blood flow pattern to reduce thrombogenicity. 
Because of that improved gas exchange performance, it is 
possible to provide a lesser heat exchange surface area 
compared to conventional heat exchangers, allowing a more 
compact unit. 
With reference to FIG. 5, a cylinder 34 is disposed in an 
interior of the heat exchanging tubule array 22, Within 
cylinder 34, a flexible membrane 36 is disposed to define a 
pneumatic pump 38. Pump inlet and outlet valves 40, 42, in 
an embodiment being duck-bill valves of known configu-
ration, prevent other than a uni-directional blood flow 
through the pneumatic pump 38 (see arrows). 
A pump gas inlet/outlet 44 is connected to a pneumatic 
console (not shown) for providing gas to operate the pneu-
matic pump 38. Pump gas is cyclically supplied to and 
withdrawn from the pump gas inlet/outlet 44, causing the 
flexible membrane 36 to expand and contract, providing a 
pumping action to promote blood flow. As shown in FIGS. 
2 and 5, when gas is supplied to the pump gas inlet/outlet 44 
US 9,468,557 B2 
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(systole), the flexible membrane 36 collapses, closing the 
pump inlet valve 40 and forcing blood out of the pneumatic 
pump 38 via the now open outlet valve 42 to pass over the 
heat exchanging tubule array 22. When gas is withdrawn 
from the pump gas inlet/outlet 44 (diastole), the flexible 
membrane 36 expands, closing the pump outlet valve 42 and 
opening the pump inlet valve 40, generating negative pres-
sure and drawing blood into the pneumatic pump 38 from 
the patient's body through the now-open pump inlet valve 
6 
negative and blood is almost always draining from the 
patient and into the atrium. In turn, very little resistance is 
imposed to transfer of blood from the atrium 100 into the 
heat exchanger 10 to fill the pneumatic pump 38, since when 
pump gas is withdrawn from the heat exchanger 10 pneu-
matic pump 38 (diastole, see FIGS. 6a and 7), the internal 
pressure of the atrium 100 is zero at its highest, i.e. slightly 
higher than the internal pressure of the heat exchanger 10 
40 (FIG. 5). On the next cycle, the blood is delivered from 10 
the pneumatic pump 38 as described above. 
pneumatic pump 38. By this mechanism, transfer of blood 
from the atrium 100 to the heat exchanger 10 pneumatic 
pump 38 is promoted by that slight pressure differential. 
These differentials are shown graphically in FIG. 7. Of 
course, the more even and non-pulsatile blood flow pattern 
established between the atrium 100 and the heat exchanger 
10 achieved by the present mechanism should not be con-
fused with the pulsatile flow established for blood passing 
through the heat exchanger 10 via the heat exchanger 
pneumatic pump 38, for the benefits described above. 
The present heat exchanger 10 will typically be supplied 
In an embodiment, a heat exchanger 10 was fabricated 
having an integral pneumatic pump 38 with an outer diam-
eter of approximately 20 mm. In bench tests using 37% 
glycerin in a mock blood flow circuit, this device was shown 15 
to provide a pumping rate of from 1.251 Llmin at 40 beats 
per minute to 3.2 Llmin at 90 beats per minute against 100 
mm Hg afterload, which was more than sufficient to meet a 
benchmark of 1-1.5 Llmin. Heat exchange efficiency for this 
device was above 70% at a flow rate of 1-1.5 Llmin. 20 with blood from a patient's body by a carmula. A dual lumen 
carmula such as those described in U.S. Pat. No. 7,473,239 
and/or U.S. Published PatentAppl. No. US 2011/0040241 is 
preferred, which both passes blood from a patient's body via 
a withdrawal carmula into the oxygenator 10 and passes 
By the foregoing design, a heat exchanger 10 is possible 
which provides a desired circuit blood flow rate of 0.5-2.0 
Llmin, an therapeutic hyperthermia dose of 42 C for 120 
min, a heating period of less than 40 minutes, an infusion 
blood temperature of 44 C or less, and stable hemodynam-
ICS. 
In another aspect, an atrium 100 is provided which further 
improves blood flow through the heat exchanger 10 of the 
present disclosure (see FIGS. 6a and 6b). In an embodiment, 
the atrium 100 is defined by at least one additional pneu-
matic pump 102, disposed at or defining the blood inlet of 
the heat exchanger 10. As shown the at least one additional 
pneumatic pump 102 is configured substantially as described 
above for the integral pneumatic pump 38 of the heat 
exchanger 10, including a pneumatic cylinder 104 and 
flexible membrane 106, and a gas inlet/outlet 108. For 
convenience and compactness, the atrium outlet valve may 
define the inlet valve 40 for the heat exchanger 10 integrated 
pneumatic pump 38, although of course the valve structures 
may be entirely separate. 
The atrium 100 operates in systolic and diastolic phases as 
described for the heat exchanger 10 pneumatic pump 38. 
That is, cyclically supplying gas to the gas inlet/outlet 108 
causes the atrium pneumatic pump 102 flexible membrane 
106 to expand and collapse. passing blood through the 
pneumatic pump 102 and into the heat exchanger 10. 
In use, the atrium 100 is kept primarily in a state of 
negative internal pressure by withdrawal of gas, with the 
exception of a time immediately prior to the diastolic phase 
of the heat exchanger 10 pneumatic pump 38 (see FIG. 7). 
Typically, the atrium 100 internal pressure is substantially 
zero at the highest, i.e. during diastole. This is accomplished 
by intermittently discontinuing withdrawal of gas from the 
atrium 100 (as distinguished from affirmatively supplying 
gas to the atrium 100 pneumatic pump 102). In contrast, the 
heat exchanger 10 pneumatic pump 38 is provided only a 
very short phase of negative internal pump pressure (see 
FIG. 7). In diastole, when an internal pressure of the atrium 
100 pneumatic pump 102 is highest, an internal pressure of 
the heat exchanger 10 pneumatic pump 38 is made slightly 
negative by withdrawal of gas (see FIG. 7). 
By this design, the skilled artisan will appreciate that a 
consistent flow of blood is established into the inlet of the 
heat exchanger 10 compared to the pulsatile and irregular 
entry of blood into heat exchangers established by conven-
tional designs. This is because the internal pressure of the 
atrium 100 into which blood first flows is almost always 
25 blood back into the patient's body via a delivery cannula. 
The dual lumen cannula may be inserted through a small 
incision into the right jugular vein, via the superior vena 
cava and traversing the right atrium, with the tip positioned 
in the inferior vena cava. This has the further advantage of 
30 reducing the length of the defined blood flow circuit and 
thereby the length of the vv-PISH circuit, reducing the 
length of time blood is exposed to potentially damaging heat 
and also the amonnt of heat required to raise the blood 
temperature to a desired level, and further eliminates mul-
35 tiple and potentially dangerous (to the patient)cannulations. 
In combination with the pump-integrated heat exchanger 10 
of the present disclosure, use of a dual lumen cannula allows 
shortening the vv-PISH circuit to lfw'h that of prior art 
systems. Blood contact surface area, circuit resistance, and 
40 circuit heat loss are significantly reduced, improving effi-
ciency, reliability, and performance. 
An electronically controlled pneumatic console may be 
provided to drive the above-described pneumatic pump 38. 
Because the pump-integrated heat exchanger 10 includes a. 
45 pneumatic pump 38 of lesser capacity than is needed to drive 
a conventional heat exchanger, a more compact pneumatic 
console is possible. 
There is accordingly provided by the present disclosure a 
compact, efficient heat exchanger 10 which provides a 
50 pulsatile, evenly dispersed blood flow therethrough, aug-
menting heat exchange performance and in turn allowing a 
lessened heat exchange surface area providing a necessary 
level of heating of blood, to allow a more compact and 
efficient design. The heat exchanger 10 may include an 
55 atrium 100 defined by one or more additional pneumatic 
pumps 102, for regulating and providing an even blood 
supply from a patients'circulatory system into the heat 
exchanger 10. The heat exchanger 10 finds use in a variety 
of procedures, including supplementing conventional cancer 
60 chemotherapy regimens. Unlike conventional heat 
exchanger designs, the present heat exchanger 10 reduces or 
eliminates regions of stagnant or limited blood flow leading 
to thrombosis and device occlusion/failure, and further pro-
vides a pulsatile flow which also decreases stagnant blood 
65 flow and reduces thrombogenicity. 
In turn, the integrated pump design of the heat exchanger 
10 eliminates connectors and tubing such as are found in 
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conventional heat exchanger/non-integral pump designs, 
reducing resistance to blood flow and improving pump 
performance. The combined integrated pump/heat 
exchanger lung design simplifies and shortens the vv-PISH 
circuit in that only one component is provided in the circuit, 
and further increases pump efficiency by eliminating blood 
flow resistance from connections between the pump and the 
artificial lung. 
One of ordinary skill in the art will recognize that addi-
tional embodiments of the invention are also possible with- 10 
out departing from the teachings herein. For example, the 
above-described vv-PISH system may optionally include a 
dialysis unit (not shown) for use in patients with compro-
mised kidney function. The dialysis unit may he connected 15 
via connectors (not shown) on the heat exchanger 10 blood 
inlet/outlet. Advantageously, the pressure gradient created 
by the heat exchanger 10 will drive up to 30% of the circuit 
blood flow (recirculation) through the dialysis unit, without 
requiring additional external pumps. 
This detailed description, and particularly the specific 
details of the exemplary embodiments, is given primarily for 
clarity of understanding, and no unnecessary limitations are 
20 
to be imported, for modifications will become obvious to 
those skilled in the art upon reading this disclosure and may 25 
be made without departing from the spirit or scope of the 
invention. Relatively apparent modifications, of course, 
include combining the various features of one or more 
figures or examples with the features of one or more of other 
figures or examples. 30 
What is claimed is: 
8 
a housing, a blood inlet ending at a distal-most surface 
of the compact heat exchanger and defining a lon-
gitudinal axis, a blood outlet, a heated fluid inlet, and 
a heated fluid outlet; 
a hollow tubule heat exchange array disposed within an 
interior of the housing for heat exchange to and from 
blood passing through the compact heat exchanger; 
an inlet blood flow redirector disposed at a distal-most 
end of the blood inlet and configured to redirect a 
flow of the blood radially to the longitudinal axis 
across the compact heat exchanger distal-most sur-
face and therefrom to the hollow tubule heat 
exchange array, the blood perfusing therefrom to the 
blood outlet; and 
a pneumatic pump disposed substantially within the 
blood inlet and within a perimeter defined by the 
housing, further wherein the pneumatic pump is 
disposed in an interior of the hollow tubule heat 
exchange array; 
a pneumatic console for cyclically supplying and with-
drawing gas to and from the compact heat exchanger 
to operate the pneumatic pump and thereby pass the 
blood over the compact heat exchanger hollow 
tubule heat exchange array; 
another pump for passing heated fluid through the 
compact heat exchanger hollow tubule heat 
exchange array; 
and a dual lumen cannula for withdrawing the blood 
from a patient body, passing the blood through the 
compact heat exchanger, and returning the blood to 
the patient body. 
1. A compact heat exchanger for vena-venous perfusion-
induced hyperthermia, comprising: 
a housing, a blood inlet ending at a distal-most surface of 
the compact heat exchanger and defining a longitudinal 
axis, a blood outlet, a heated fluid inlet, and a heated 
fluid outlet; 
7. The vena-venous perfusion-induced hyperthermia sys-
tem of claim 6, wherein the pneumatic console and pneu-
35 matic pump provide a blood flow rate of from about 0.5 to 
about 2 Llminute. 
a hollow tubule heat exchange array disposed within an 
interior of the housing for heat exchange to and from 40 
blood passing through the compact heat exchanger; 
an inlet blood flow redirector disposed at a distal-most 
end of the blood inlet and configured to redirect a flow 
of the blood radially to the longitudinal axis across the 
compact heat exchanger distal-most surface and there- 45 
from to the hollow tubule heat exchange array, the 
blood perfusing therefrom to the blood outlet; and 
a pneumatic pump disposed substantially within the blood 
inlet and within a perimeter defined by the housing, 
further wherein the pneumatic pump is disposed in an 50 
interior of the hollow tubule heat exchange array. 
2. The heat exchanger of claim 1, wherein the pneumatic 
pump provides a blood flow rate of from about 0.5 to about 
2 Llminute. 
3. The heat exchanger of claim 2, wherein a heat exchang- 55 
ing surface area of the hollow tubule heat exchange array is 
optimal for heating the blood passing therethrough at a flow 
rate of from about 0.5 to about 2 Llminute to a blood 
temperature of up to 44 C for delivery to a patient body. 
4. The heat exchanger of claim 1, wherein the hollow 60 
tubule heat exchange array is fabricated of a suitable heat 
exchanging metal. 
5. The heat exchanger of claim 4, wherein the suitable 
heat exchanging metal is stainless steel. 
6. A vena-venous perfusion-induced hyperthermia sys- 65 
tern, comprising: 
a compact heat exchanger comprising: 
8. The vena-venous perfusion-induced hyperthermia sys-
tem of claim 7, wherein a heat exchanging surface area of 
the hollow tubule heat exchange array is optimal for heating 
the blood passing therethrough at a flow rate of from about 
0.5 to about 2 Llminute to a blood temperature of up to 44 
C for delivery to a patient body. 
9. The vena-venous perfusion-induced hyperthermia sys-
tem of claim 8, wherein the hollow tubule heat exchange 
array is fabricated of a suitable heat exchanging metal. 
10. The vena-venous perfusion-induced hyperthermia 
system of claim 9, wherein the suitable heat exchanging 
metal is stainless steel. 
11. A compact heat exchanger for vena-venous perfusion-
induced hyperthermia, comprising: 
a housing, a blood inlet ending at a distal-most surface of 
the compact heat exchanger and defining a longitudinal 
axis, a blood outlet, a heated fluid inlet, and a heated 
fluid outlet; 
a hollow tubule heat exchange array disposed within an 
interior of the housing for heat exchange to and from 
blood passing through the compact heat exchanger; 
an inlet blood flow redirector disposed at a distal-most 
end of the blood inlet, the inlet blood flow redirector 
including a conical tip extending into an interior lumen 
of the distal-most end of the blood inlet for evenly 
dispersing the blood radially to the longitudinal axis 
across the compact heat exchanger distal-most surface 
and therefrom to the hollow tubule heat exchange array, 
the blood perfusing therefrom to the blood outlet; and 
a pneumatic pump disposed substantially within the blood 
inlet and within a perimeter defined by the housing, 
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further wherein the pneumatic pump is disposed in an 
interior of the hollow tubule heat exchange array. 
* * * * * 
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